Lessee, Operating Lease, Liability, Undiscounted Excess Amount of China SXT Pharmaceuticals, Inc. from 30 Sep 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
China SXT Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Sep 2024 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Mar 2025 was $12,984.
China SXT Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in CNY history and change rate from 30 Sep 2024 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Mar 2025 was ¥94,219.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (CNY)

China SXT Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $12,984 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 $54,330 30 Sep 2024 6-K 28 Mar 2025 2025 Q2

China SXT Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥94,219 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 ¥381,276 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.